세계의 자궁경 검사 시술 시장 보고서(2025년)
Hysteroscopy Procedures Global Market Report 2025
상품코드 : 1824286
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,448,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,320,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,193,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 자궁경 검사 시술 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년까지 CAGR 7.5%로 확대되어 57억 8,000만 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 지속적인 연구와 기술 혁신, 계발 캠페인 증가, 진단 정밀도의 향상, 지속적인 트레이닝 프로그램, 외래 수술 증가, 저침습 수술에 대한 기호 증가 등에 기인하는 것으로 예측됩니다. 예측기간의 주요 동향으로는 외래수술 수요 증가, 영상기술 진보, 로봇공학의 통합, 불임치료에 대한 주력, 진단범위 확대 등이 있습니다.

향후 5년간의 성장률 7.5%라는 예측은 지난 예측으로부터 0.1% 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 타국 간의 관세의 영향 때문입니다. 관세 상승은 한국과 이탈리아에서 조달한 자궁경 절제 시스템과 체액 관리 장치의 가격을 끌어올려 부인과 수술 비용을 악화시키고 저침습 치료를 지연시킴으로써 미국 병원에 부담을 줄 가능성이 높습니다. 또한 상호 관세와 무역 긴장 증가와 제한으로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 더 광범위하게 가해질 수 있습니다.

예상되는 부인과 질환의 유병률 상승은 자궁경 검사 시술 시장의 성장을 가속하는 요인입니다. 자궁근종, 월경 장애, 다낭성 난소 증후군과 같은 증상을 포함하는 부인과 질환은 여성 생식기계의 정상적인 기능을 방해합니다. 자궁경 검사 기술은 이상자궁출혈, 과다월경출혈, 불규칙한 점상출혈, 폐경후 출혈로 이어지는 문제를 진단 및 치료함으로써 부인과 질환의 발생 증가에 대처하고 예방하는데 중요한 역할을 하고 있습니다. 특히 2023년 1월 National Center for BIoTechnology Information이 발표한 종이제에서는 70% 이상의 여성이 폐경까지 자궁근종을 발병하고 임상적으로 눈에 띄는 자궁근종은 임신가능한 나이의 여성의 25%에 영향을 미친다고 강조하고 있습니다. 게다가 세계보건기구(WHO)의 2023년 3월 기사에 따르면 자궁내막증은 세계 생식연령의 여성과 여성의 약 10%(1억 9,000만 명)에 영향을 미쳤습니다. 그 결과, 부인과 질환의 급증이 자궁경 검사 시술 시장의 확대에 박차를 가하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

A hysteroscopy is a diagnostic technique that allows a surgeon to examine the interior of the uterus. It involves the use of a hysteroscope to identify symptoms or problems such as heavy periods, abnormal vaginal bleeding, postmenopausal bleeding, pelvic pain, recurrent miscarriages, or difficulties in conception.

The primary types of products used in hysteroscopy procedures include flexible hysteroscopes, forceps, rigid hysteroscopes, and scissors. Flexible hysteroscopy is considered a secure, efficient, and reliable method for investigating abnormal uterine bleeding. These instruments find applications in various procedures such as hysteroscopy, endometrial ablation, myomectomy, polypectomy, among others, and are utilized by different end-users such as hospitals, clinics, ambulatory surgery centers, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The hysteroscopy procedure market research report is one of a series of new reports from The Business Research Company that provides hysteroscopy procedure market statistics, including hysteroscopy procedure industry global market size, regional shares, competitors with a hysteroscopy procedure market share, detailed hysteroscopy procedure market segments, market trends, and opportunities, and any further data you may need to thrive in the hysteroscopy procedure industry. This hysteroscopy procedure market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hysteroscopy procedures market size has grown strongly in recent years. It will grow from $4.06 billion in 2024 to $4.32 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to collaboration with gynecologists, diagnostic accuracy improvement, evolving training and education, growth in outpatient procedures, minimally invasive surgery trend.

The hysteroscopy procedures market size is expected to see strong growth in the next few years. It will grow to $5.78 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to continued research and innovation, increasing awareness campaigns, enhanced diagnostic accuracy, ongoing training programs, outpatient procedure growth, rising preference for minimally invasive surgery. Major trends in the forecast period include increasing demand for outpatient procedures, advancements in imaging technologies, integration of robotics, focus on fertility treatments, and expansion of diagnostic scope.

The forecast of 7.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. hospitals by driving up the cost of hysteroscopic resection systems and fluid management devices sourced from South Korea and Italy, exacerbating gynecological surgical expenses and delaying minimally invasive care. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in the prevalence of gynecological problems is poised to drive the growth of the hysteroscopy procedure market. Gynecological disorders, encompassing conditions such as uterine fibroids, menstrual disorders, and polycystic ovarian syndrome, disrupt the normal functioning of the female reproductive system. Hysteroscopy procedures play a crucial role in addressing and preventing an increased occurrence of gynecological ailments by diagnosing and treating issues leading to abnormal uterine bleeding, excessive menstrual bleeding, irregular spotting, and postmenopausal bleeding. Notably, a January 2023 article from the National Center for Biotechnology Information highlighted that over 70% of women develop uterine fibroids by the onset of menopause, and clinically noticeable uterine fibroids affect 25% of women in their fertile age. Additionally, a March 2023 article from the World Health Organization reported that endometriosis impacts nearly 10% (190 million) of reproductive-age women and girls globally. Consequently, the surging prevalence of gynecological problems is fueling the expansion of the hysteroscopy procedure market.

The rising demand for minimally invasive procedures is expected to drive the growth of the hysteroscopy procedures market in the future. Minimally invasive procedures involve medical techniques and surgical interventions characterized by small incisions, specialized instruments, and advanced imaging technology used for diagnosis, treatment, or surgical interventions within the body. This growing preference for minimally invasive options significantly contributes to the expansion of hysteroscopy procedures, driven by factors such as patient preference, enhanced outcomes, technological advancements, and cost-effectiveness, making these procedures more appealing to both patients and healthcare providers. For instance, a report from The Aesthetic Society, a U.S.-based organization focused on plastic surgery and cosmetic medicine, revealed that Americans spent over $11.8 billion on aesthetic procedures in total, representing a 2% increase from the previous year. Thus, the increasing demand for minimally invasive procedures is propelling the growth of the hysteroscopy procedures market.

Leading companies in the hysteroscopy procedures market are concentrating on creating innovative solutions, such as hysteroscopic tissue removal systems, to simplify and enhance the minimally invasive nature of these procedures. A hysteroscopic tissue removal system is a minimally invasive medical device designed for the resection or removal of abnormal tissues within the uterus, utilizing hysteroscopy for real-time visualization and precise treatment. For example, in July 2023, GenWorks Health Private Limited, an India-based equipment and technology solutions firm, introduced a mechanical hysteroscopic tissue removal system. This device facilitates the minimally invasive extraction of intrauterine tissues during hysteroscopic procedures. It employs a straightforward mechanical method, allowing the hysteroscope to be inserted into the uterus, where soft tissue shavers simultaneously cut and aspirate abnormal tissues, such as endometrial fibroids and polyps. Its design enables direct visualization of the intrauterine cavity, ensuring accurate targeting of abnormalities while allowing for tissue collection for pathological analysis. By reducing the dependence on energy discharge and minimizing fluid usage, this system enhances safety and efficiency, leading to shorter procedure times and improved patient outcomes. With a streamlined process that requires fewer steps and only a single insertion, it serves as a valuable tool in gynecological practice.

Major players in the hysteroscopy procedures market are concentrating on introducing innovative products, such as the Hystero-V single-use hysteroscope, to capitalize on the advantages of single-use technology. The Hystero-V, developed by UroViu, offers several benefits for both physicians and patients, including convenience, safety, cost-effectiveness, and portability. In June 2022, UroViu Corporation launched the Hystero-V single-use hysteroscope, positioning it as a significant advancement in single-use hysteroscopy technology. This device is poised to capture a considerable share of the growing global hysteroscope market.

In January 2024, Stille AB, a medical technology company based in Sweden, acquired Fehling Instruments for an undisclosed amount. This acquisition is intended to broaden Stille AB's product portfolio and strengthen its position in the surgical instruments market by incorporating Fehling's innovative solutions and expertise. Fehling Instruments, located in Germany, specializes in developing and manufacturing precision instruments and medical devices specifically for surgical applications.

Major companies operating in the hysteroscopy procedures market include Hologic Inc., CooperSurgical Inc., Stryker Corp., Karl Storz SE & Co. KG, Medtronic plc, Johnson & Johnson Services Inc., Olympus Corporation, B. Braun SE, Richard Wolf GmbH, Erbe Elektromedizin GmbH, Boston Scientific Corporation, MedGyn Products Inc., LiNA Medical ApS, LUMINELLE, Meditrina Inc., Maxer Endoscopy GmbH, Smith & Nephew plc, Cook Medical LLC, Fujifilm Holdings Corporation, ConMed Corporation, Silex Medical LLC, EndoChoice Holdings Inc., Endo Optiks Inc., Hysteroscopy Centers of America LLC

North America was the largest region in the hysteroscopy procedure market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hysteroscopy procedure market report during the forecast period. The regions covered in the hysteroscopy procedures market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hysteroscopy procedures market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hysteroscopy procedure market consists of revenues earned by entities by providing diagnostic and operative hysteroscopy services. The market value includes the value of related goods sold by the service provider or included within the service offering. The hysteroscopy procedures market consists of sales of hysteroscopes, hysterosheaths, and hysteroscopic tissue removal systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hysteroscopy Procedures Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hysteroscopy procedures market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for hysteroscopy procedures ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hysteroscopy procedures market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Hysteroscopy Procedures Market Characteristics

3. Hysteroscopy Procedures Market Trends And Strategies

4. Hysteroscopy Procedures Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Hysteroscopy Procedures Growth Analysis And Strategic Analysis Framework

6. Hysteroscopy Procedures Market Segmentation

7. Hysteroscopy Procedures Market Regional And Country Analysis

8. Asia-Pacific Hysteroscopy Procedures Market

9. China Hysteroscopy Procedures Market

10. India Hysteroscopy Procedures Market

11. Japan Hysteroscopy Procedures Market

12. Australia Hysteroscopy Procedures Market

13. Indonesia Hysteroscopy Procedures Market

14. South Korea Hysteroscopy Procedures Market

15. Western Europe Hysteroscopy Procedures Market

16. UK Hysteroscopy Procedures Market

17. Germany Hysteroscopy Procedures Market

18. France Hysteroscopy Procedures Market

19. Italy Hysteroscopy Procedures Market

20. Spain Hysteroscopy Procedures Market

21. Eastern Europe Hysteroscopy Procedures Market

22. Russia Hysteroscopy Procedures Market

23. North America Hysteroscopy Procedures Market

24. USA Hysteroscopy Procedures Market

25. Canada Hysteroscopy Procedures Market

26. South America Hysteroscopy Procedures Market

27. Brazil Hysteroscopy Procedures Market

28. Middle East Hysteroscopy Procedures Market

29. Africa Hysteroscopy Procedures Market

30. Hysteroscopy Procedures Market Competitive Landscape And Company Profiles

31. Hysteroscopy Procedures Market Other Major And Innovative Companies

32. Global Hysteroscopy Procedures Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hysteroscopy Procedures Market

34. Recent Developments In The Hysteroscopy Procedures Market

35. Hysteroscopy Procedures Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기